Michal F Kaminski and colleagues report that colonoscopy screening reduced colorectal cancer incidence, but not mortality, during a 13-year follow-up.1 The response from the public health field will ...

The starting age dropped, a blood test joined the list, and there's now an age doctors say to quit.

Mail-based screening programs are helping more Americans stay up to date with colorectal cancer tests—often with a simple box ...

SAN DIEGO — In the ever-expanding options for colorectal cancer (CRC) screening, blood tests using precision medicine are becoming more advanced and convenient than ever; however, caveats abound, and ...

Please provide your email address to receive an email when new articles are posted on . New blood and stool tests may improve uptake of colorectal cancer screening because of the discomfort around ...

A recent study published in JAMA identified colorectal cancer as the leading cause of cancer-related deaths among Americans ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...

Invitations to patients eligible for colorectal cancer screening need not be limited to office visits. A 2018 systematic review and meta-analysis of 73 randomized clinical trials of U.S.-based ...

The Global Colon Screening Market is expected to reach US$ 23.51 billion by 2033 from US$ 16.45 billion in 2024, with a CAGR of 4.05% from 2025 to 2033. Major drivers propelling this market's growth ...

Cancer mortality for individuals aged under 50 years in Canada has significantly decreased for nine of the 10 deadliest ...

We thank João Martins and Aneel Bhangu, Hermann Brenner and colleagues, and Uri Ladabaum and colleagues for their interesting comments on our report from the NordICC trial.1 We agree with Martins and ...